project id: TCGA-CESC; case submitter id: TCGA-C5-A1BJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.7; spectrophotometer method: UV Spec; age at index: 34; days to birth: -12611; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 12611; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4385.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 4972; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-C5-A1BJ-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;